Table 5. Results of oncological follow-up of cervical cancer patients (n = 43).

Follow-up	Measurement
Follow-up time in months, median (IQR)▵	32 (28)
Fatality rate (person-years)	5/100
Global survival at 2 years (%)	82.9
Relapse rate (person-years)	5.7/100
Recurrence (n)	6/35
Local recurrence rate (%)	9
Time to relapse in months, median (IQR)▵	20.9 (9.26)
Disease-free interval in months, median (IQR)▵	24,2(24,2)
Persistence (n/ total)	7/43
Deaths (n/ total)	6/43

^▵Interquartile range